LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Technical Replicate | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 3.3333 | uM | 0 | uM | 3 | 2 | 280 | 1109 | 588 | 2.6141 | |
| BT-20 | Lapatinib | 1.9245 | uM | 0 | uM | 1 | 1 | 2751 | 7730 | 4757 | 2.6962 | |
| BT-20 | Alpelisib | 0.0400 | uM | NVP-TAE684 | 0.3704 | uM | 3 | 2 | 280 | 1242 | 588 | 3.0176 |
| BT-20 | NVP-TAE684 | 0.3704 | uM | 0 | uM | 3 | 1 | 280 | 1127 | 554 | 3.1163 | |
| BT-20 | NVP-TAE684 | 0.3704 | uM | 0 | uM | 3 | 2 | 280 | 1291 | 588 | 3.1656 |